Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Ads

You May Also Like

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

FOCUS trial to continue without modificationNEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath ...

Pluristem Issues Letter to Shareholders

HAIFA, Israel, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a ...

Histogenics Corporation to Announce Second Quarter 2017 Financial Results on August 10, 2017

WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine ...